Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bp Consulting, Inc
With
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female over 18 yrs.
Female subjects of childbearing potential must have negative pregnancy test and provide contraception.
Subjects must have confirmed diagnosis of primary open-angle glaucoma or ocular hypertension in both eyes.
Subjects who are or have been insufficiently responsive to IOP reducing monotherapy and use of either study medication is deemed appropriate.
Subjects able to complete questionnaires and provide informed consent.
You may not be if
Female subjects who are pregnant, planning to become pregnant during study period, breast feeding or not practicing a reliable method of birth control.
Subjects wherein the study drugs are containdicated.
Subjects who have had introcular surgery with 6 months (3 months for laser).
Subjects with known side effects/ allergy or sensitivity to any component of study treatments.
Subjects with any uncontrolled systemic disease.
Clareo Health | Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
